Fed. Circ. Revives Sanofi Bid To Amend Cancer Drug Patent
The Federal Circuit on Tuesday tossed the Patent Trial and Appeal Board's invalidation of proposed amended claims for a Sanofi patent covering the prostate cancer drug Jevtana, finding the board improperly...To view the full article, register now.
Already a subscriber? Click here to view full article